CYH
Community Health Systems, Inc.
CYH trails on the overall score without a compensating advantage in the available component scores.
UNH
UnitedHealth Group Incorporated
UNH has the edge over CYH overall, supported by lower modeled downside and stronger modeled upside.
CYH Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Weak |
CYH's profitability is currently stable, but its revenue, cash flow and balance sheet are under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
CYH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 1.3x | $0.35 | -84% |
| Fair | 2x | $0.55 | -75% |
| Expensive | 4.4x | $1.18 | -47% |
| Current | 8.2x | $2.21 | — |
Historical ranges are pointers, not guarantees.
CYH's PE is in its expensive range at 8.2x.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH has the edge over CYH in the historical PE scenario, which offers more potential upside but is not a forecast.
CYH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| Stable | |
| Limited | |
| Low |
Analysts expect CYH's losses to grow, with revenue declining. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over CYH on the outlook, with more favorable earnings and revenue expectations.
CYH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.27 | -89% |
| Q2 2026 | $1.86 | +$3.35 |
| Q1 2026 | $3.44 | +$7.12 |
| Q4 2025 | $3.77 | +$7.67 |
| Q3 2025 | $2.42 | +$5.43 |
| Q2 2025 | -$1.49 | -$0.74 |
| Q1 2025 | -$3.68 | -$2.74 |
| Q4 2024 | -$3.90 | -$2.88 |
CYH has the edge over UNH on earnings, with more consistent year-over-year improvement.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
CYH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | -11% |
| Q2 2026 | $2.8B | -9.8% |
| Q1 2026 | $3B | -6.1% |
| Q4 2025 | $3.1B | -4.9% |
| Q3 2025 | $3.1B | -0.1% |
| Q2 2025 | $3.1B | -0.2% |
| Q1 2025 | $3.2B | +0.6% |
| Q4 2024 | $3.3B | +2.6% |
CYH's revenue has slid since its 2019 peak: $2.8B last quarter, down 11% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.3% | -2.6 points |
| Q2 2026 | 14% | -2.6 points |
| Q1 2026 | 9.5% | +0.5 points |
| Q4 2025 | 14% | +6 points |
| Q3 2025 | 7.9% | +15 points |
| Q2 2025 | 16% | +8.8 points |
| Q1 2025 | 9% | +1.6 points |
| Q4 2024 | 8.5% | -1.8 points |
CYH's operating margin was 5.3% last quarter, down 2.6 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over CYH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over CYH on profitability, with a higher operating margin.
CYH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $67M | +1575% |
| Q2 2026 | $12M | +$15M |
| Q1 2026 | -$373M | -1166% |
| Q4 2025 | $172M | +61% |
| Q3 2025 | $4M | +$7M |
| Q2 2025 | -$3M | -123% |
| Q1 2025 | $35M | +1067% |
| Q4 2024 | $107M | +$127M |
CYH's free cash flow was −$122M over the past year, against $143M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over CYH on cash generation, producing positive trailing cash flow while its opponent burns cash.
CYH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.7% | -963K shares |
| 1 year | +0.3% | +355K shares |
| 3 years | +3.7% | +4.8M shares |
| 5 years | +3.6% | +4.7M shares |
| Available history | +19% | +21.6M shares |
CYH has 136M diluted shares, about the same as a year ago.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over CYH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
CYH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.5x | High |
| Q2 2026 | 5.2x | High |
| Q1 2026 | 4.9x | High |
| Q4 2025 | 5.3x | High |
| Q3 2025 | 5.9x | High |
| Q2 2025 | 7.9x | High |
| Q1 2025 | 10.2x | High |
| Q4 2024 | 11.1x | High |
CYH's net debt is about 5.5 years of its operating earnings (EBITDA), down from 5.9 years a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over CYH on leverage, with a lower net debt burden relative to earnings.
CYH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.4 | Neutral |
| Stochastic | 19.0 | Oversold |
CYH's weekly RSI is 34 (neutral) and its Stochastic is 19 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
CYH PE vs Healthcare Sector
| Metric | CYH | Sector median | Relative |
|---|---|---|---|
| PE | 8.2x | 26x | 68% below |
| PE % | 92 | 29 | 63 pts above |
CYH has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
CYH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.63 | 16% below |
| 20 week MA | $2.90 | 24% below |
| 50 week MA | $3.03 | 27% below |
| 100 week MA | $3.09 | 28% below |
| 200 week MA | $3.55 | 38% below |
CYH is in a downtrend: it's below all five of its weekly moving averages, and 38% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over CYH on trend strength, trading above more of its moving averages.
CYH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.77 | $7.67 | +177% |
| 2021 | $7.67 | $13.3 | +73% |
| 2022 | $13.3 | $3.88 | -71% |
| 2023 | $3.88 | $3.13 | -19% |
| 2024 | $3.13 | $3.03 | -3.2% |
| 2025 | $3.03 | $3.23 | +6.6% |
| 2026 YTD | $3.23 | $2.21 | -32% |
CYH's yearly returns have swung widely, from +177% in 2020 to −71% in 2022. It's down 32% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over CYH on returns for 2026, with the stronger performance.